U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07325383) titled 'Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT Patients' on Nov. 16, 2025.
Brief Summary: Oral mucositis (OM) is one of the most frequent complications in patients who undergo HSCT. It not only causes severe discomfort but also affects treatment adherence and increases hospital stays. In this study, we aim to assess whether using N-acetylcysteine mouthwash can safely and effectively prevent OM. The trial is randomized and conducted in the hematology wards of TUMS-affiliated RIOHCT, including both autologous and allogeneic HSCT patients.
Study Start Date: Aug. 18, 2024
Study Type: INTERVENTIONAL...